RIVM is conducting various studies on immunity (resistance) after a SARS-CoV-2 infection or vaccination against the coronavirus SARS-CoV-2. An overview of the current RIVM studies on this topic is presented here. 

Information materials on the breast cancer screening programme in the Caribbean Netherlands are available in Spanish, Papiamento, English and Dutch.

Prof. Cécile van Els, professor of vaccinology,  answers two questions about the AstraZeneca vaccine. How well does the AstraZeneca vaccine protect against COVID-19 and can you choose which vaccine you will receive? More questions and answers about COVID-19 vaccines

RIVM  is an independent agency of the Dutch Ministry of Health, Welfare and Sport (VWS). Our tasks and responsibilities, and how we ensure our independence have been laid down in the RIVM act of 21 October 1996.